Latest Insider Transactions at Volitionrx LTD (VNRX)
This section provides a real-time view of insider transactions for Volitionrx LTD (VNRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VOLITIONRX LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VOLITIONRX LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2024
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
12,984
+10.53%
|
-
|
|
Jun 01
2024
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
8,011
+16.28%
|
-
|
|
Jun 01
2024
|
Nicholas Plummer GC - Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
10,249
+7.11%
|
-
|
|
Jun 01
2024
|
Salvatore Thomas Butera CEO - Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
31,256
+11.93%
|
-
|
|
Jun 01
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,686
+3.41%
|
-
|
|
Jun 01
2024
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
8,011
+12.98%
|
-
|
|
Jun 01
2024
|
Jasmine Kway CEO - Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
13,570
+10.28%
|
-
|
|
Jun 01
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,709
+11.98%
|
-
|
|
Jun 01
2024
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
16,022
+2.4%
|
-
|
|
Jun 01
2024
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,689
+3.72%
|
-
|
|
Jun 01
2024
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,944
+6.12%
|
-
|
|
Jun 01
2024
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
90,182
+4.66%
|
-
|
|
Jun 01
2024
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,326
+7.14%
|
-
|
|
Jun 01
2024
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
12,016
+5.7%
|
-
|
|
Jun 01
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,685
+11.93%
|
-
|
|
May 23
2024
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
May 01
2024
|
Salvatore Thomas Butera CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
15,504
-7.21%
|
$0
$0.87 P/Share
|
|
Jan 24
2024
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+15.69%
|
-
|
|
Jan 24
2024
|
Jasmine Kway CEO - Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
28,475
+21.35%
|
-
|
|
Jan 24
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,375
+8.29%
|
-
|
|
Jan 24
2024
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+1.32%
|
-
|
|
Jan 24
2024
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,925
+11.19%
|
-
|
|
Jan 24
2024
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,925
+16.82%
|
-
|
|
Jan 24
2024
|
Edward Futcher |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+9.56%
|
-
|
|
Jan 24
2024
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,150
+2.78%
|
-
|
|
Jan 24
2024
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+4.35%
|
-
|
|
Jan 24
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,525
+23.19%
|
-
|
|
Jan 24
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,150
+9.42%
|
-
|
|
Jan 24
2024
|
Salvatore Thomas Butera CEO - Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
36,125
+14.39%
|
-
|
|
Jan 24
2024
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
18,700
+16.11%
|
-
|
|
Jan 24
2024
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+20.39%
|
-
|
|
Jan 24
2024
|
Nicholas Plummer GC - Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
29,325
+19.16%
|
-
|
|
Jan 24
2024
|
Mickie Henshall |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+23.81%
|
-
|
|
Jan 24
2024
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,525
+1.28%
|
-
|
|
Jan 02
2024
|
Eight Corp LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,000
-6.28%
|
$0
$0.9 P/Share
|
|
Dec 18
2023
|
Salvatore Thomas Butera CEO - Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
10,000
+9.14%
|
$0
$0.83 P/Share
|
|
Dec 15
2023
|
Eight Corp LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,000
-5.91%
|
$0
$0.75 P/Share
|
|
Dec 15
2023
|
Salvatore Thomas Butera CEO - Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
10,000
+10.07%
|
$0
$0.77 P/Share
|
|
Dec 13
2023
|
Rodney Gerard Rootsaert Secretary |
BUY
Open market or private purchase
|
Direct |
10,000
+11.28%
|
$0
$0.6 P/Share
|
|
Dec 08
2023
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.58%
|
$0
$0.67 P/Share
|
|
Nov 27
2023
|
Edward Futcher |
BUY
Open market or private purchase
|
Direct |
9,000
+11.12%
|
$0
$0.8 P/Share
|
|
Nov 27
2023
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
20,000
+3.09%
|
$0
$0.77 P/Share
|
|
Nov 24
2023
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
10,000
+1.62%
|
$0
$0.76 P/Share
|
|
Nov 22
2023
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
20,000
+3.24%
|
$0
$0.71 P/Share
|
|
Nov 16
2023
|
Salvatore Thomas Butera CEO - Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
10,000
+11.19%
|
$0
$0.81 P/Share
|
|
Oct 19
2023
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+25.92%
|
-
|
|
Oct 19
2023
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+2.83%
|
-
|
|
Oct 19
2023
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+25.15%
|
-
|
|
Oct 19
2023
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+10.56%
|
-
|
|
Oct 04
2023
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,527
-5.13%
|
$0
$0.68 P/Share
|